Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Curr Opin Biotechnol. 2018 Nov 1;58:1–8. doi: 10.1016/j.copbio.2018.10.005

Figure 2.

Figure 2.

Cell membrane-coated nanoparticles for nanodelivery. (a) RBC membrane-coated nanoparticles are functionalized with the surface markers from the original cell, which makes them well-suited for drug delivery due to their ability to circulate for extended periods of time in the bloodstream. Adapted with permission from [23]. (b) Platelet membrane-coated nanoparticles are immunocompatible and can target different disease substrates, including antibiotic-resistant bacteria and damaged vasculature. Adapted with permission from [32].